CH652306A5 - Verfahren zur herstellung einer pharmazeutischen, parenteralen dosiseinheit des natriumsalzes von piperacillin. - Google Patents

Verfahren zur herstellung einer pharmazeutischen, parenteralen dosiseinheit des natriumsalzes von piperacillin. Download PDF

Info

Publication number
CH652306A5
CH652306A5 CH1857/82A CH185782A CH652306A5 CH 652306 A5 CH652306 A5 CH 652306A5 CH 1857/82 A CH1857/82 A CH 1857/82A CH 185782 A CH185782 A CH 185782A CH 652306 A5 CH652306 A5 CH 652306A5
Authority
CH
Switzerland
Prior art keywords
concentration
piperacillin
pharmaceutical
lyophilized
solution
Prior art date
Application number
CH1857/82A
Other languages
German (de)
English (en)
Inventor
Bruce Edwin Haeger
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22935482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CH652306(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of CH652306A5 publication Critical patent/CH652306A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CH1857/82A 1981-03-26 1982-03-25 Verfahren zur herstellung einer pharmazeutischen, parenteralen dosiseinheit des natriumsalzes von piperacillin. CH652306A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24758681A 1981-03-26 1981-03-26

Publications (1)

Publication Number Publication Date
CH652306A5 true CH652306A5 (de) 1985-11-15

Family

ID=22935482

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1857/82A CH652306A5 (de) 1981-03-26 1982-03-25 Verfahren zur herstellung einer pharmazeutischen, parenteralen dosiseinheit des natriumsalzes von piperacillin.

Country Status (23)

Country Link
JP (1) JPS57159708A (es)
AT (1) AT395533B (es)
AU (1) AU549784B2 (es)
BE (1) BE892541A (es)
CA (1) CA1209477A (es)
CH (1) CH652306A5 (es)
DE (2) DE3208505A1 (es)
DK (1) DK157976C (es)
ES (1) ES8302455A1 (es)
FR (1) FR2502624B1 (es)
GB (1) GB2095551B (es)
GR (1) GR78386B (es)
HK (1) HK39189A (es)
HU (1) HU186489B (es)
IE (1) IE52936B1 (es)
IL (1) IL64924A (es)
IT (1) IT1147916B (es)
LU (1) LU84031A1 (es)
NL (1) NL192664C (es)
NZ (1) NZ199632A (es)
PL (1) PL130564B1 (es)
SE (1) SE453153B (es)
ZA (1) ZA82605B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207661B1 (en) 1999-02-22 2001-03-27 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
JP4836797B2 (ja) 2003-10-23 2011-12-14 大塚製薬株式会社 放出制御性無菌注射アリピプラゾール製剤および方法
ITMI20051630A1 (it) * 2005-09-02 2007-03-03 Acs Dobfar Spa Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi
AR067747A1 (es) 2007-07-31 2009-10-21 Otsuka Pharma Co Ltd Metodos para producir suspension de aripiprazol y formulacion liofilizada
CN114200057A (zh) * 2021-12-14 2022-03-18 坛墨质检科技股份有限公司 一种可替代标准溶液的抗生素类药物固体混合标准物质的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2608507A (en) * 1949-08-20 1952-08-26 Sharp & Dohme Inc Dialkyl sulfamyl benzoic acids
CH546783A (de) * 1971-03-11 1974-03-15 Hoffmann La Roche Verfahren zur herstellung von penicilloinsaeurederivate.
JPS5817728B2 (ja) * 1973-11-20 1983-04-09 山之内製薬株式会社 アンピシリンナトリウムエン ノ セイホウ
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
JPS52143221A (en) * 1976-05-22 1977-11-29 Yamanouchi Pharmaceut Co Ltd Novel preparations for rectal administration
DE2623835C2 (de) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von Natriumampicillin
JPS542337A (en) * 1977-06-08 1979-01-09 Toyama Chem Co Ltd Bactericidal composition for medical use
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
JPS54147917A (en) * 1978-05-08 1979-11-19 Sumitomo Chem Co Ltd Ferrze-drying method
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
PL130564B1 (en) 1984-08-31
ATA92982A (de) 1992-06-15
DE19375106I2 (de) 2006-02-16
GB2095551B (en) 1984-10-03
IT8248034A0 (it) 1982-03-19
HU186489B (en) 1985-08-28
SE8200591L (sv) 1982-09-27
DE3208505C2 (es) 1991-11-28
DK157976B (da) 1990-03-12
GB2095551A (en) 1982-10-06
IL64924A0 (en) 1982-04-30
NL192664C (nl) 1997-12-02
SE453153B (sv) 1988-01-18
DK157976C (da) 1990-08-27
AT395533B (de) 1993-01-25
NL8201251A (nl) 1982-10-18
JPH0219804B2 (es) 1990-05-07
JPS57159708A (en) 1982-10-01
HK39189A (en) 1989-05-19
FR2502624A1 (fr) 1982-10-01
CA1209477A (en) 1986-08-12
ES509234A0 (es) 1982-12-16
DE3208505A1 (de) 1982-10-21
GR78386B (es) 1984-09-26
NL192664B (nl) 1997-08-01
PL235509A1 (es) 1982-12-20
FR2502624B1 (fr) 1985-10-25
IE820703L (en) 1982-09-26
DK48382A (da) 1982-09-27
NZ199632A (en) 1985-07-12
AU549784B2 (en) 1986-02-13
ES8302455A1 (es) 1982-12-16
IE52936B1 (en) 1988-04-13
IT1147916B (it) 1986-11-26
AU7986582A (en) 1982-09-30
BE892541A (fr) 1982-09-20
IL64924A (en) 1985-07-31
LU84031A1 (de) 1982-07-08
ZA82605B (en) 1982-12-29

Similar Documents

Publication Publication Date Title
DE1617374C2 (de) Verfahren zum Herstellen eines pharmazeutischen Präparates mit verzögerter analgetischer Wirkung
DE69028710T2 (de) Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung
DE68904922T2 (de) Piroxicam in waessrigen loesungen enthaltende arzneizubereitungen und verfahren zu deren herstellung.
DE69621942T2 (de) Verbessertes herstellungsverfahren und zusammensetzung für therapeutisches cisplatin (cddp)
DE2323686A1 (de) Arzneimittelzubereitungsform mit langzeitwirkung und verfahren zu ihrer herstellung
DE1492015A1 (de) Verbesserte Verabreichungsform pharmazeutischer Praeparate
DE69027220T2 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
DE2545973B2 (de) Verfahren zur Herstellung eines Digoxinarzneimittels in Form von therapeutischen Einzeldosen
DE3782117T2 (de) Verkapselung von trh bzw. dessen analoga.
DE69904727T2 (de) Injizierbares arzneimittel auf basis eines pharmazeutisch verträglichen salzes von clopidogrel bzw. von ticlopidin
DE3536560A1 (de) Augentropfen enthaltend bromokryptin
AT397460B (de) Verfahren zur herstellung eines pharmazeutischen trockenpräparates enthaltend ein diclofenac-salz
DE4038385C2 (de) Sitosterol und seine Glykoside mit verbesserter Bioverfügbarkeit
CH652306A5 (de) Verfahren zur herstellung einer pharmazeutischen, parenteralen dosiseinheit des natriumsalzes von piperacillin.
DE60101979T2 (de) Lösung enthaltend N-[O-(p-pivaloyloxybenzenesulfonylamino)benzoyl]glyzin Mononatriumsalz Tetrahydrat und diese Lösung enthaltendes Arzneimittel
EP0277462A1 (de) Verfahren zur Herstellung nasaler Lösungen enthaltend synthetisches Human calcitonin.
CH647677A5 (de) 4'-(acridinylamino)-methansulfon-anisidid enthaltende pharmazeutische zusammensetzung.
DE2719581A1 (de) Polyhydroxyphenylchromanone enthaltende arzneimittel
DE69400190T2 (de) Verfahren zum herstellen von arzneizusammensetzungen, die vecuroniumbromid enthalten
WO2000056325A2 (de) Ibuprofen-lösung
DE69132145T2 (de) Peritoneal wirksame medikamente
DE2401450A1 (de) Pharmazeutische zusammensetzung zur linderung von hautproliferationserkrankungen
DE2117762A1 (de) Behandlung von Alopecia und pharmazeutische Präparation für die Durchführung der Behandlung
DE2349186C2 (de) Arzneimittel zur Verbesserung der Zellatmung, der Herzmuskelleistung und der Hirnfunktion
DE925375C (de) Verfahren zur Herstellung eines Procain-Penicillin-G-Praeparates

Legal Events

Date Code Title Description
PL Patent ceased